Literature DB >> 29168936

Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

Hiroaki Shimamoto1,2, Tristan R Grogan3, Tomomi Tsujimoto1, Naoya Kakimoto4, Shumei Murakami1, David Elashoff3, Tara L Aghaloo5, Sotirios Tetradis2.   

Abstract

OBJECTIVES: To evaluate the impact of cone beam CT (CBCT) in the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaw (MRONJ).
METHODS: For 15 patients with suspected Stage 0 MRONJ, clinical photographs, a panoramic radiograph and selected CBCT sections were identified. 13 oral surgeons reviewed the material and answered 10 questions in two different sessions. First session included clinical photographs and panoramic radiographs, while second session also included CBCT images. Questions (Qs) referred to dental disease and bone abnormalities (Qs 1, 2 and 3), differential diagnosis (Qs 4 and 5), patient management (Qs 6 and 7) and prognosis (Qs 8 and 9). Q 10 queried indication (first session) and usefulness (second session) of CBCT images.
RESULTS: Qs 2, 3, 5, 7 and 9 scores increased between sessions, with statistical differences for Qs 2, 3, 5 and 7 (<0.05). Patients 2, 8 and 11 showed a significant increase in the average score of all Qs between sessions, while scores for patient 10 nearly reached statistical significance (p = 0.055). For Q 10, 57.4% of answers reported that CBCT was needed (first session) and was beneficial (second session).
CONCLUSIONS: CBCT had a significant impact in differential diagnosis and management of patients with suspected Stage 0 MRONJ.

Entities:  

Mesh:

Year:  2017        PMID: 29168936      PMCID: PMC6047633          DOI: 10.1259/dmfr.20170290

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  40 in total

1.  Osteonecrosis of the jaw in a patient with advanced non-small-cell lung cancer receiving bevacizumab.

Authors:  Stamatis Katsenos; Charalampos Christophylakis; Konstantinos Psathakis
Journal:  Arch Bronconeumol       Date:  2012-03-17       Impact factor: 4.872

2.  Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.

Authors:  Kenneth E Fleisher; Steven Doty; Shailesh Kottal; Joan Phelan; Robert G Norman; Robert S Glickman
Journal:  J Oral Maxillofac Surg       Date:  2008-12       Impact factor: 1.895

3.  Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

Authors:  Luis Junquera; Lorena Gallego
Journal:  J Oral Maxillofac Surg       Date:  2008-07       Impact factor: 1.895

4.  Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.

Authors:  Vittorio Fusco; Claudia Galassi; Alfredo Berruti; Libero Ciuffreda; Cinzia Ortega; Giovannino Ciccone; Alberto Angeli; Oscar Bertetto
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.

Authors:  Valentina Guarneri; David Miles; Nicholas Robert; Véronique Diéras; John Glaspy; Ian Smith; Christoph Thomssen; Laura Biganzoli; Tanya Taran; PierFranco Conte
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

6.  Sunitinib related osteonecrosis of jaw: a case report.

Authors:  Yoram Fleissig; Eran Regev; Hadas Lehman
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-01-02

7.  Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

Authors:  Hani Mawardi; Nathaniel Treister; Paul Richardson; Kenneth Anderson; Nikhil Munshi; Robert A Faiella; Sook-Bin Woo
Journal:  J Oral Maxillofac Surg       Date:  2009-03       Impact factor: 1.895

8.  Bisphosphonate-related osteonecrosis of the jaw: model and diagnosis with cone beam computerized tomography.

Authors:  C Barragan-Adjemian; L Lausten; D B Ang; M Johnson; J Katz; L F Bonewald
Journal:  Cells Tissues Organs       Date:  2008-08-15       Impact factor: 2.481

9.  Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

Authors:  Felice S O'Ryan; Sam Khoury; Wendy Liao; Myo M Han; Rita L Hui; David Baer; Daniel Martin; Donald Liberty; Joan C Lo
Journal:  J Oral Maxillofac Surg       Date:  2009-07       Impact factor: 1.895

10.  Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Authors:  F Saad; J E Brown; C Van Poznak; T Ibrahim; S M Stemmer; A T Stopeck; I J Diel; S Takahashi; N Shore; D H Henry; C H Barrios; T Facon; F Senecal; K Fizazi; L Zhou; A Daniels; P Carrière; R Dansey
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

View more
  5 in total

1.  Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws.

Authors:  Akrivoula Soundia; Danny Hadaya; Sanjay M Mallya; Tara L Aghaloo; Sotirios Tetradis
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-08-29

Review 2.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

Review 3.  Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Sven Otto; Suad Aljohani; Riham Fliefel; Sara Ecke; Oliver Ristow; Egon Burian; Matthias Troeltzsch; Christoph Pautke; Michael Ehrenfeld
Journal:  Medicina (Kaunas)       Date:  2021-05-09       Impact factor: 2.430

Review 4.  Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication).

Authors:  Makoto Tsuchimochi; Tohru Kurabayashi
Journal:  Jpn Dent Sci Rev       Date:  2019-01-17

Review 5.  Medication-related Osteonecrosis of the Jaw: A Review.

Authors:  Nouf A AlDhalaan; Asma BaQais; Ahmad Al-Omar
Journal:  Cureus       Date:  2020-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.